Alterola Biotech, Inc.
ABTI
$0.001
-$0.0003-23.08%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 82.70K | 714.30K | 2.70K | 2.60K | 9.10K |
Total Receivables | 1.06M | -- | -- | -- | -- |
Inventory | 1.10K | 1.00K | 1.00K | 1.00K | 1.00K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 187.10K |
Total Current Assets | 1.15M | 715.30K | 3.70K | 3.60K | 197.20K |
|
|||||
Total Current Assets | 1.15M | 715.30K | 3.70K | 3.60K | 197.20K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 60.00K | -- | -- | -- | 300.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 157.00K | 260.00K | -- | -- | -- |
Total Assets | 1.36M | 975.20K | 3.70K | 3.60K | 497.20K |
|
|||||
Total Accounts Payable | 805.30K | 868.20K | 825.20K | 803.80K | 722.10K |
Total Accrued Expenses | 462.00K | 460.60K | 362.50K | 310.50K | 246.40K |
Short-term Debt | 2.35M | 1.11M | 145.60K | 244.10K | 1.55M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 3.62M | 2.44M | 1.33M | 1.36M | 2.52M |
|
|||||
Total Current Liabilities | 3.62M | 2.44M | 1.33M | 1.36M | 2.52M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 2.35M | 1.11M | 145.60K | 244.10K | 1.55M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.62M | 2.44M | 1.33M | 1.36M | 2.52M |
|
|||||
Common Stock & APIC | 11.69M | 11.57M | 11.05M | 11.05M | 8.36M |
Retained Earnings | -13.67M | -12.98M | -12.42M | -12.44M | -10.43M |
Treasury Stock & Other | -75.20K | 35.60K | 39.90K | 40.00K | 49.60K |
Total Common Equity | -2.06M | -1.38M | -1.33M | -1.35M | -2.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.06M | -1.38M | -1.33M | -1.35M | -2.02M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -196.30K | -88.90K | -- | -- | -- |
Total Equity | -2.25M | -1.46M | -1.33M | -1.35M | -2.02M |
|